Data / Form D filings / Tendyne Holdings, Inc.
Tendyne Holdings, Inc.: Form D filings
Tendyne Holdings, Inc., a biotechnology company in Roseville, MN, filed 5 Form D notices with the SEC between 2012 and 2014. The latest, on April 24, 2014, reports $25 million sold of a $25 million offering to 6 investors.
Find out what Tendyne Holdings, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2825 FAIRVIEW AVENUE NORTH, Roseville, MN, 55113
- Phone
- (651) 289-5500
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2010
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1557648
The full lists. Form D filings in Minnesota: 692 rows, $34.60, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 24, 2014 | Amendment | $24,999,998 | $24,999,998 | $0 | 6 | Mar 11, 2014 | sec.gov |
| Mar 24, 2014 | New notice | $24,999,998 | $20,999,999 | $3,999,999 | 2 | Mar 11, 2014 | sec.gov |
| Mar 7, 2014 | New notice | $1,000,000 | $1,000,000 | $0 | 1 | Feb 24, 2014 | sec.gov |
| May 20, 2013 | Amendment | $23,000,000 | $11,476,197 | $11,523,803 | 20 | Sep 18, 2012 | sec.gov |
| Sep 25, 2012 | New notice | $23,000,000 | $8,976,427 | $14,023,573 | 20 | Sep 18, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Greg W. Pearl | Director | |
| Jeffrey Franco | Executive Officer, Director | |
| David W. McIntyre | Director | |
| Edward W. Malouf | Director | |
| Joseph W. Smith | Director |
Other biotechnology companies in Minnesota that filed recently
- Medical 21, Inc. $550,000 · Oct 23, 2026
- InSitu Biologics, Inc. $1.3 million · Oct 14, 2026
- Evia Bio, Inc. $5.5 million · Sep 28, 2026
- EyeMacular Regeneration, Inc. $2.9 million · Sep 25, 2026
- ProEncia Biotechnology Inc. $1.5 million · Aug 26, 2026
Every Form D from the week of Apr 21, 2014 · All recent filings in Minnesota · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Tendyne Holdings, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.